Diagnosis and treatment of chronic hepatic encephalopathy. 1998

J P Seery, and R J Aspinall, and S D Taylor-Robinson
Robert Steiner Magnetic Resonance Unit, Imperial College School of Medicine, Hammersmith Hospital, London.

Neuropsychiatric abnormalities affecting patients with chronic liver disease are termed chronic hepatic encephalopathy. They involve neurotransmitter changes, rather than a structural disorder of the brain. Diagnosis is based on clinical findings, and electroencephalographic and psychometric testing. There is no 'specific' treatment, but there are a number of non-specific measures that can be used.

UI MeSH Term Description Entries
D011581 Psychological Tests Standardized tests designed to measure abilities (as in intelligence, aptitude, and achievement tests) or to evaluate personality traits. Parenting Stress Index,Trier Social Stress Test,Trier Stress Test,Psychologic Tests,Psychological Test,Test, Psychological,Tests, Psychological,Index, Parenting Stress,Psychologic Test,Stress Index, Parenting,Stress Test, Trier,Test, Psychologic,Test, Trier Stress,Trier Stress Tests
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

J P Seery, and R J Aspinall, and S D Taylor-Robinson
June 2013, Compendium (Yardley, PA),
J P Seery, and R J Aspinall, and S D Taylor-Robinson
December 2000, Bailliere's best practice & research. Clinical gastroenterology,
J P Seery, and R J Aspinall, and S D Taylor-Robinson
August 2019, Gastroenterology & hepatology,
J P Seery, and R J Aspinall, and S D Taylor-Robinson
August 1970, Lancet (London, England),
J P Seery, and R J Aspinall, and S D Taylor-Robinson
January 2001, Wiadomosci lekarskie (Warsaw, Poland : 1960),
J P Seery, and R J Aspinall, and S D Taylor-Robinson
January 2021, Przeglad gastroenterologiczny,
J P Seery, and R J Aspinall, and S D Taylor-Robinson
September 2011, Journal of clinical and experimental hepatology,
J P Seery, and R J Aspinall, and S D Taylor-Robinson
July 1998, Digestion,
J P Seery, and R J Aspinall, and S D Taylor-Robinson
October 1991, Hepato-gastroenterology,
J P Seery, and R J Aspinall, and S D Taylor-Robinson
March 2012, Deutsches Arzteblatt international,
Copied contents to your clipboard!